secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001213900-23-032547
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity raises $7.5M in public offering; restructures debt and preferred stock with 3i, LP
--------------------------------------------------------------------------------

- Gross proceeds $7.5M from offering of 2.87M shares, pre-funded warrants for 7.13M shares, and common warrants for 10M shares at $0.85.
- 3i, LP provided $350K loan converted to 486 Series A shares; exchanged Series C for 4,027 Series A shares.
- Company paid $3.35M to cancel all outstanding debt to 3i and repurchased 1,550 Series A shares for $1.65M.
- Series A preferred stock amended: redemption right and dividend eliminated; conversion price set at $0.75.
- Exchange warrant issued to 3i for 12.6M common shares at $0.75 exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023032547/0001213900-23-032547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023032547/ea177302-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-032547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer